Results 111 to 120 of about 4,278 (174)
IntroductionOral squamous cell carcinoma (OSCC) is the most prevalent oral malignancy, with emerging interest in the characterization of its tumor microenvironment.
Vasileios Ionas Theofilou +15 more
doaj +1 more source
Abstracts From PVRI 2026 Dublin
Pulmonary Circulation, Volume 16, Issue 2, June 2026.
wiley +1 more source
Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways. [PDF]
Jiang H +12 more
europepmc +1 more source
The semaphorin 4D (Sema4D) receptor plexin-B1 constitutively interacts with particular Rho guanine nucleotide exchange factors (RhoGEFs) and thereby mediates Sema4D-induced RhoA activation, a process which involves the tyrosine phosphorylation of plexin ...
Swiercz, J. M. +2 more
core
Retraction notice to
Zhou H +6 more
europepmc +1 more source
OBJECTIVES: Enterococcus faecalis is a major bacterial pathogen associated with endodontic infections and contributes considerably to periapical periodontitis. This study aimed to investigate the potential mechanisms by which E. faecalis accounts for the
Deng, Z +5 more
core
Signaling mechanisms of plexin -B1: A receptor for semaphorin 4D.
The adult nervous system is an intricate map of neurons that forms precise connections to allow for the functioning of the human body. During development of the nervous system, neurons send out projections to sense the environment.
Aurandt, Jennifer Lynn
core
The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma [PDF]
Growth and metastasis of solid tumors requires induction of angiogenesis to ensure the delivery of oxygen, nutrients and growth factors to rapidly dividing transformed cells. Through either mutations, hypoxia generated by cytoreductive therapies, or when
PROIA, Patrizia +4 more
core
Retraction Note to: Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. [PDF]
Zhou H +4 more
europepmc +1 more source

